Targeting the cyclin-binding groove site to inhibit the catalytic activity of CDK2/cyclin A complex using p27(KIP1)-derived peptidomimetic inhibitors

Functionally activated cyclin-dependent kinase 2 (CDK2)/cyclin A complex has been validated as an interesting therapeutic target to develop the efficient antineoplastic drug based on the cell cycle arrest. Cyclin A binds to CDK2 and activates the kinases as well as recruits the substrate and inhibit...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Chem Biol
Главные авторы: Karthiga, Arumugasamy, Tripathi, Sunil Kumar, Shanmugam, Ramasamy, Suryanarayanan, Venkatesan, Singh, Sanjeev Kumar
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2014
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286569/
https://ncbi.nlm.nih.gov/pubmed/25584078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12154-014-0124-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы